We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Enzyme Discovered May Lead to Better TB Test

By LabMedica International staff writers
Posted on 31 Jan 2013
An enzyme has been identified that will trigger the rapid breakdown of several Mycobacteria, which could lead to better tests for the deadly tuberculosis infection.

The current bacterial culture test for tuberculosis infections is highly accurate but time-consuming, taking up to several weeks, while the diagnostic process called nucleic acid-based amplification (NAA) faces difficulty in breaking open, or lysing bacteria. More...


Scientists at University of Pittsburgh Graduate School of Public Health (PA, USA) show that exposure to an enzyme called esterase from Mycobacterium smegmatis hydrolyzes the ester linkage of trehalose dimycolate in vitro, which triggers the rapid and efficient lysis of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium marinum.

A rapid and efficient lysis of trehalose dimycolate hydrolase (TDMH) exposed M. tuberculosis, and a subsequent release of nucleic acids (NA) offered a unique opportunity to use this enzyme for achieving more sensitive detection in a nucleic acid amplification assay for the diagnosis of tuberculosis (TB). The nucleic content in the supernatant of TDMH-exposed bacilli started to increase within 30 minutes of exposure, and it peaked at around 60 minutes.

Treatment of samples with TDMH prior to the amplification reaction facilitated the NA detection in 37 samples, a highly significant improvement in the numbers of positive detection. The investigators also demonstrated that this quick lysis of M. tuberculosis improved its detection at lower density.

Anil Ojha, PhD, an assistant professor and senior author of the study said, "Tuberculosis is a huge public health burden. Clearly, controlling the infection is heavily dependent upon an effective diagnosis. Discovery of enzyme-based mycobacteria lysis has the potential to increase the sensitivity of NAA." The study was published on January 4, 2013, in the Journal of Biological Chemistry.

Related Links:
University of Pittsburgh


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
All-in-One Molecular System
AIO M160
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers identified eight new DNA pattern signatures that could help refine diagnostics and guide targeted therapy in breast cancer (image credit: 123RF)

Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.